@article{a5254ac38d7f40498439b6918210af8a,
title = "Tapping into the biology of Alzheimer disease",
author = "Knopman, {David S.}",
note = "Funding Information: Dr. Knopman serves as Deputy Editor of Neurology {\textregistered}; has served on data safety monitoring boards for Sanofi-Aventis, GlaxoSmithKline, and Eli Lilly and Company; is an investigator in clinical trials sponsored by Elan Corporation, Baxter International Inc., and Forest Laboratories, Inc.; and receives research support from the NIH (R01-AG023195 [PI], R01-AG11378 [Co-I], P50 AG16574 [Co-I], U01 AG 06786 [Co-I], and R01 HL70825 [Co-I]).",
year = "2011",
month = feb,
day = "8",
doi = "10.1212/WNL.0b013e31820af995",
language = "English (US)",
volume = "76",
pages = "496--497",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "6",
}